期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Study on the antitumor effects of autologous and allogeneic CIK cells in patients with breast cancer
1
作者 Xia Chen Zhijian Dai +3 位作者 Xiangji Lu Meng Ren Zhenshan Guo Yanwei Gao 《Oncology and Translational Medicine》 CAS 2021年第2期65-68,共4页
Objective This study aimed to compare the anti-tumor effects of cytokine-induced killer (CIK) cellsinduced by autologous cytokines in patients with breast cancer and those of allogeneic CIK cells fromhealthy adults.Me... Objective This study aimed to compare the anti-tumor effects of cytokine-induced killer (CIK) cellsinduced by autologous cytokines in patients with breast cancer and those of allogeneic CIK cells fromhealthy adults.Methods We used conventional methods to induce CIK cells originating from two peripheral bloodmononuclear cell types (from patients with breast cancer and healthy adults). Killing activity was detectedusing an LDH assay, immunophenotypic changes were analyzed by flow cytometry, and the IFN-γ level ofculture supernatants was detected by ELISA.Results The results showed that the proliferative capacity of the allogeneic CIK cells was significantlyhigher than that of the autologous CIK cells. Compared with autologous CIK cells, the allogeneic CIK cellshad significantly enhanced anti-tumor activity against SKBR-3 cells (P < 0.01) and IFN-γ secretion (P <0.05);moreover, they increased the ratio of CD3+ CD56+ cells and CD3+ CD8+ cells (P < 0.05).Conclusion Healthy adult-derived induced CIK cells exhibited a stronger anti-tumor effect than inducedCIK cells derived from patients with breast cancer. The results of this study could provide experimentalevidence for the clinical application of CIK cells. 展开更多
关键词 cik cells AUTOLOGOUS ALLOGENEIC cellular immunotherapy breast cancer
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部